Stryker Expands Vascular Device Portfolio with Acquisition Stryker's acquisition broadens its medical device offerings, enhancing solutions for vascular health. Learn more about this strategic expansion.
Eli Lilly Rises 1.6% While ResMed Falls 4% in Monday Trading Eli Lilly experiences a 1.6% midday rise, boasting a 34% year-to-date gain, while ResMed sees a 4% decline, affecting stock market trends in pharmaceuticals and medical devices.